(Q46108266)

19 December 2017

title

5HT-2 mediation of acute behavioral effects of hallucinogens in rats (English)

1 reference

19 December 2017

author name string

L L Wing

series ordinal

1

1 reference

19 December 2017

G S Tapson

series ordinal

2

1 reference

19 December 2017

M A Geyer

series ordinal

3

1 reference

19 December 2017

publication date

1 January 1990

1 reference

19 December 2017

published in

Psychopharmacology

1 reference

19 December 2017

volume

100

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

417-425

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/bf02244617

exact match

0 references

cites work

A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02244617

Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02244617

Evidence that 5-HT agonist-induced rotational behaviour in the rat is mediated via 5-HT1 receptors

21 January 2018

1 reference

12 December 2020

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors

1 reference

12 December 2020

Effects of DOM and DMT in a proposed animal model of hallucinogenic activity

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists

1 reference

12 December 2020

5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests

1 reference

12 December 2020

Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide

1 reference

12 December 2020

Psychotomimetic phenylisopropylamines. 5. 4-Alkyl-2,5-dimethoxyphenylisopropylamines

1 reference

12 December 2020

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1 reference

12 December 2020

Spike and wave complexes produced by four hallucinogenic compounds in the cat.

1 reference

12 December 2020

Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.

1 reference

12 December 2020

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

Dopaminergic activity of quipazine.

1 reference

12 December 2020

LSD-induced alterations of locomotor patterns and exploration in rats.

1 reference

12 December 2020

Depletion of brain serotonin by 5,7-dihydroxytryptamine alters the response to amphetamine and the habituation of locomotor activity in rats.

1 reference

12 December 2020

LSD-induced alterations of investigatory responding in rats

1 reference

12 December 2020

8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist

1 reference

12 December 2020

Evidence that serotonin mediates some behavioral effects of amphetamine

1 reference

12 December 2020

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

12 December 2020

Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors

1 reference

12 December 2020

Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system.

1 reference

12 December 2020

Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.

1 reference

12 December 2020

Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses

1 reference

12 December 2020

Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat.

1 reference

12 December 2020

Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens

1 reference

12 December 2020

Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons.

1 reference

12 December 2020

The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle

1 reference

12 December 2020

Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome

1 reference

12 December 2020

Selective 5-HT1B agonists identify the 5-HT autoreceptor in lumbar spinal cord of rat

1 reference

12 December 2020

[3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes

1 reference

12 December 2020

Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.

1 reference

12 December 2020

A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats.

1 reference

12 December 2020

A characteristic effect of hallucinogens on investigatory responding in rats

1 reference

12 December 2020

Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244617

1 reference

19 December 2017

1 reference

19 December 2017